Loading...
Disclaimer: Informational only — not medical advice. AI hypotheses are not clinically validated. Medic Oath is for informational and educational purposes only — not medical advice. AI-generated hypotheses have not been clinically validated. Always consult a qualified healthcare professional. Privacy · Terms
2-Hydroxyglutaric aciduria is a group of neurometabolic disorders with a wide clinical spectrum ranging from severe neonatal presentations to progressive forms, and asymptomatic cases, characterized biochemically by increased levels of 2-hydroxyglutaric acid in the plasma, cerebrospinal fluid and urine.
Metformin activates AMPK-mediated enhancement of 2-hydroxyglutarate dehydrogenase expression while nicotinamide riboside supplementation provides cofactor support for the NAD+-dependent enzymatic clearance of accumulated 2-HG. This combination addresses both enzyme insufficiency and cofactor depletion in 2-hydroxyglutaric aciduria.
Pharmacological riboflavin doses (100-400mg) act as a chemical chaperone for misfolded L2HGDH enzyme variants, restoring proper protein conformation and FAD cofactor binding. Enhanced enzyme stability increases residual 2-hydroxyglutarate dehydrogenase activity in patients with hypomorphic mutations.
Baicalin from Scutellaria baicalensis upregulates IDH1/2 wild-type enzyme activity through allosteric modulation while chrysin inhibits 2-hydroxyglutarate dehydrogenase degradation via HSP90 stabilization. This dual mechanism reduces pathological 2-HG accumulation while enhancing residual metabolic capacity in affected neurons.
Cell-permeable α-ketoglutarate analogs competitively inhibit 2-hydroxyglutarate binding to α-KG-dependent dioxygenases, preventing epigenetic dysregulation and metabolic disruption. Modified α-KG esters bypass normal transport limitations and restore proper cofactor availability for TET and JmjC demethylases.
Withanoside VI from Withania somnifera crosses blood-brain barrier and activates SIRT3-mediated mitochondrial biogenesis while inhibiting NMDA receptor hyperactivation caused by elevated 2-hydroxyglutarate. The compound also enhances glutathione synthesis via Nrf2 pathway activation, countering oxidative stress in 2-HGA patients.
Ar-turmerone from turmeric essential oil modulates organic anion transporters OAT1 and OAT3 to enhance 2-hydroxyglutarate efflux from brain tissue while simultaneously inhibiting monocarboxylate transporter-mediated re-uptake. This creates a favorable gradient for 2-HG clearance from the CNS compartment.
Unkei-to combination (Coptis chinensis, Evodia rutaecarpa, Ginseng) provides berberine and evodiamine compounds that inhibit microglial activation via TLR4-MyD88-NF-κB pathway suppression. The formula reduces neuroinflammatory cascades triggered by 2-hydroxyglutarate accumulation in brain tissue.